Wuppertal, Germany

Gerd Reinhardt


Average Co-Inventor Count = 5.5

ph-index = 6

Forward Citations = 220(Granted Patents)


Company Filing History:


Years Active: 1978-1998

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Gerd Reinhardt: Pioneering Peptide Therapeutics

Introduction: Gerd Reinhardt, an accomplished inventor based in Wuppertal, Germany, has made significant contributions to the field of biotechnology. With a total of seven patents, his work primarily focuses on peptide therapeutics, particularly related to the bovine pancreatic trypsin inhibitor, also known as aprotinin.

Latest Patents: Reinhardt's latest innovations include variants of bovine pancreatic trypsin inhibitors produced by recombinant DNA technology. These peptides possess specific sequences wherein amino acids at positions 15, 16, 17, 18, 34, 39, and 52 are replaced by naturally occurring amino acids. The use of these peptides extends to therapeutic applications in treating diseases linked with excessive proteinases, highlighting their potential as impactful medical agents.

Career Highlights: Throughout his career, Reinhardt has been affiliated with Bayer Aktiengesellschaft, a global leader in pharmaceuticals and life sciences. His dedication to research and innovation has allowed him to contribute valuable inventions to the industry, enhancing therapeutic options for patients.

Collaborations: Reinhardt has collaborated with notable colleagues, including Eugen Schnabel and Ernst-August Auerswald. These partnerships reflect the integrative approach taken within the scientific community to advance research and develop effective treatments.

Conclusion: Gerd Reinhardt stands out as a leading inventor in the realm of peptide therapeutics. His work on bovine pancreatic trypsin inhibitors not only showcases his innovative prowess but also emphasizes the importance of collaboration in advancing medical science. With ongoing developments in this field, Reinhardt's contributions will likely continue to shape future therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…